Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1542.9000 17.30 (1.13%)
NSE May 05, 2025 15:31 PM
Volume: 786.9K
 

logo
Cipla Ltd.
25 Jan 2023
1542.90
1.13%
CIPLA LTD. - 500087 - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine …
BSE India
The Board of Directors of the Company at its meeting held today i.e., 25th January 2023, has inter-alia approved the unaudited financial results (standalone and consolidated) for the quarter and nine months ended 31st December 2022. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed as follows: (1) Unaudited financial results (standalone and consolidated) as per Indian Accounting Standards, for the quarter and nine months ended 31st December 2022; and (2) Limited review report (standalone and consolidated) by Walker Chandiok & Co LLP, Statutory Auditor of the Company, for the quarter and nine months ended 31st December 2022. The meeting of the Board of Directors of the Company commenced at 10.30 a.m. (IST) and is still in progress.
More from Cipla Ltd.
Recommended